Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation

Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation

Item
http://www.wikidata.org/entity/Q28387314
Development of high efficiency ventilation bag actuated dry powder inhalers.Advances in device and formulation technologies for pulmonary drug delivery.Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilationEfficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.Performance of dry powder inhalers with single dosed capsules in preschool children and adults using improved upper airway modelsValidating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.Development of an Inline Dry Power Inhaler That Requires Low Air Volume.Pulmonary aerosol delivery and the importance of growth dynamics.Enhanced design of inhaled therapeutics: what does the future hold?
P2860

Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation

Item
http://www.wikidata.org/entity/Q28387314
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Evaluation and modification of ...... anced growth (EEG) formulation
@ast
Evaluation and modification of ...... anced growth (EEG) formulation
@en
Evaluation and modification of ...... anced growth (EEG) formulation
@nl
type
label
Evaluation and modification of ...... anced growth (EEG) formulation
@ast
Evaluation and modification of ...... anced growth (EEG) formulation
@en
Evaluation and modification of ...... anced growth (EEG) formulation
@nl
prefLabel
Evaluation and modification of ...... anced growth (EEG) formulation
@ast
Evaluation and modification of ...... anced growth (EEG) formulation
@en
Evaluation and modification of ...... anced growth (EEG) formulation
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Evaluation and modification of ...... anced growth (EEG) formulation
@en
P2093
P2860
P304
P31
P356
10.1016/J.EJPS.2013.04.011
P407
P433
P478
P50
P577
P5875
P698
P921
P932